A recent report has highlighted growing concerns around so-called “silent cancers” — cancers that often show few or vague symptoms until they have already progressed.
The article shares the experiences of several Australians diagnosed with cancers including pancreatic, uterine and ovarian cancer, many of which were initially difficult to detect due to their non-specific symptoms.
Pancreatic cancer is now the third leading cause of cancer death in Australia, with diagnoses in people aged 30 to 39 increasing significantly over the past two decades. Uterine cancer is also rising rapidly among younger women.
Experts say one of the biggest challenges with these cancers is that symptoms can easily be mistaken for common conditions or normal life changes. Symptoms such as abdominal pain, bloating, fatigue, irregular bleeding or appetite changes are often subtle and may not immediately point to cancer.
The report also highlights the growing importance of molecular profiling and targeted treatments, which analyse the genetic makeup of tumours to help identify more personalised treatment options and clinical trials.
Researchers and advocacy groups are continuing to push for improved awareness, earlier detection methods and better access to emerging treatments, particularly for cancers that are commonly diagnosed at later stages.
Health organisations also continue to stress the importance of routine cancer screening, awareness of persistent symptoms and reducing preventable risk factors such as smoking, heavy alcohol consumption and obesity.
